Guangzhou Wondfo BiotechLtd

SZSE:300482 Stock Report

Mkt Cap: CN¥20.8b

Guangzhou Wondfo BiotechLtd Past Performance

How has Guangzhou Wondfo BiotechLtd performed over the past 5 years?

[object Object] Score

6/6

Past Performance Score 6/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


36.4%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 300482 has high quality earnings.

Growing Profit Margin: 300482's current net profit margins (22.5%) are higher than last year (22.1%).


Past Earnings Growth Analysis

Earnings Trend: 300482's earnings have grown significantly by 36.4% per year over the past 5 years.

Accelerating Growth: 300482's earnings growth over the past year (79.3%) exceeds its 5-year average (36.4% per year).

Earnings vs Industry: 300482 earnings growth over the past year (79.3%) exceeded the Medical Equipment industry 9.1%.


Return on Equity

High ROE: 300482's Return on Equity (26.6%) is considered high.


Discover strong past performing companies